With 0.6 million shares changed hands, the volume of the stock remained heavier than its average volume of 0.55 million shares. During the session, the Medical Care Facilities company that operates in wider Healthcare sector, reached to the highest price of $5.2087 whereas the lowest price it dropped to was $4.8. The 52-week range on AIRS shows that it touched its highest point at $9.20 and its lowest point at $1.53 during that stretch. It currently has a 1-year price target of $4.75. AIRS paid its most recent dividend on 1661385600, while the ex-dividend date for that was 1661385600. Beta for the stock currently stands at 2.50.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of AIRS was down-trending over the past week, with a drop of -1.37%, but this was up by 41.46% over a month. Three-month performance surged to 94.98% while six-month performance fell -14.12%. The stock gained 21.39% in the past year, while it has lost -2.70% so far this year. A look at the trailing 12-month EPS for AIRS yields -0.30 with Next year EPS estimates of 0.01. For the next quarter, that number is 0.01. This implies an EPS growth rate of -366.66% for this year and 112.50% for next year. EPS is expected to grow by 51.83% annually over the next five years; however, over the past five years, the company experienced an annual growth rate of -29.15%.
Float and Shares Shorts:
At present, 58.66 million AIRS shares are outstanding with a float of 11.36 million shares on hand for trading. On 2025-05-30, short shares totaled 6.95 million, which was 1182.0 higher than short shares on 1745971200. In addition to Dr. Aaron J. Rollins M.D. as the firm’s Founder & Executive Chairman, Mr. Dennis Dean CPA serves as its Chief Financial Officer.
Institutional Ownership:
Through their ownership of 0.69282997 of AIRS’s outstanding shares, institutional investors have minority control over the company.
An Overview of Recent Financials:
Understanding a company as a customer does not mean you will understand it as an investor. The wise investor uses quantitative research to analyze metrics such as revenue, net income, and earnings. In its fiscal quarter reported on 2025-03-31, AIRS reported revenue of $39371000.0 and operating income of -$1589000.0. The EBITDA in the recently reported quarter was $1653000.0 and diluted EPS was -$0.05.
Analysts Ratings:
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for AIRS since 3 analysts follow the stock currently. There are 0 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 3 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential. With AIRS analysts setting a high price target of 4.5 and a low target of 4.5, the average target price over the next 12 months is 4.5. Based on these targets, AIRS could drop -10.89% to reach the target high and fall by -10.89% to reach the target low. Reaching the average price target will result in a decline of -10.89% from current levels.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of $0.13133 being high and $0.0844275 being low. For AIRS, this leads to a yearly average estimate of $0.11257.
